New York hearing on CVS-Aetna spotlights potential retail pharmacy vertical concerns

The question of whether CVS’s combination with Aetna would lead the merged company to use — and abuse — a large presence at the retail pharmacy level briefly took center stage...

Subscription required to view this article.

This content can only be accessed by FTCWatch subscribers. If you are an FTCWatch subscriber, please login to access this content

If you do not currently subscribe to FTCWatch please contact us for subscription information:

FTCWatch is delivered in the following formats: via email alert and online at